Andrew Bateman, PhD
Progranulin
neuroprotection
tissue repair
growth factors
cell communication
MeDiC | Metabolic Disorders and Complications Program
Our Researchers
The Metabolic Disorders and Complications Program (MeDiC) brings together a team of outstanding research scientists who share the goal of developing new diagnostic tools, treatments and health policies for obesity, diabetes and osteoporosis, along with their complications, including kidney failure, heart disease, fatty liver/cirrhosis, dementia and stroke.
More than one in three Canadians are affected by common and chronic metabolic disorders. The MeDiC Program unites multidisciplinary researchers to study these problems in both adults and children. Each member of the MeDiC program is also affiliated with at least one of the research centres at the Research Institute of the McGill University Health Centre: the Centre for Translational Biology, the Centre for Innovative Medicine and the Centre for Outcomes Research and Evaluation.
To learn more about the MeDiC program, visit our Events, News and Contact Us pages.
Filters
Displaying 20 result(s).
|
CTB |
|
Barry Bedell, MD, PhDImaging MRI PET image processing neuropathology CTB |
|
Stéphanie Chevalier, RD, PhDnutrition metabolism sarcopenia aging lung cancer CTB |
|
|
Andrey Cybulsky, MDcell injury glomerulonephritis phospholipases protein kinases stress proteins CTB |
|
George Fantus, MD, FRCPCInsulin resistance tyrosine kinase and phosphatase glucose metabolism diabetes complications oxidative stress CTB |
|
David Goltzman, MDcalcium and mineral metabolism hormonal regulation bone metabolism osteoporosis parathyroid disorders CTB |
|
Ahmad Haidar, PhDType 1 diabetes clinical research artificial pancreas systems automated insulin delivery system randomized controlled trials CTB |
|
|
Bertrand Jean-Claude, M.Sc., PhDKinase inhibitors anti-cancer drugs pharmacokinetics molecular modeling CTB |
|
Maia Kokoeva, PhDObesity diabetes hypothalamus leptin receptor leptin sensing CTB |
|
Richard Kremer, MD, PhDvitamin D parathyroid hormone related peptide (PTHrP) breast cancer skeletal metastasis circulating tumour cells CTB |
|
|
Stéphane Laporte, PhDG protein-coupled receptor molecular pharmacology cell imaging cardiovascular diseases pre-term birth. CTB |
|
Louise Larose, PhDintracellular signaling adaptor proteins unfolded protein response insulin resistance obesity and diabetes CTB |
|
|
Serge Lemay, MDtyrosine kinase adaptor proteins acute kidney injury cell signaling CTB |
|
Jun-Li Liu, PhDCCN5/WISP2 pancreatic islets growth and development transgenic mice knockout mice CTB |
|
|
Errol Marliss, MD, FRCPCNutrition metabolism diabetes obesity insulin resistance CTB |
|
Christian Rocheleau, PhDepidermal growth factor receptor (EGFR) Ras protein Caenorhabditis elegans Rab proteins vesicular trafficking CTB |
|
Dana Small, PhDingestive behavior decision making gut-brain axis obesity neuroimaging CTB |
|
Elena Torban, PhDkidney development planar cell polarity cilia formation and ciliophaties glomerular disease mouse models of human kidney diseases CTB |
|
Jeremy Van Raamsdonk, PhD, M.Scaging biological resilience neurodegeneration Parkinson's disease Huntington's disease CTB |